All the content of the library is provided from Mayo Clinic in English.
As a member of the Mayo Clinic Care Network, RSPP has special access to Mayo Clinic knowledge and resources.
Niemann-Pick disease is a group of rare conditions passed down in families. The conditions affect the body's ability to break down and use fats, such as cholesterol and lipids, inside cells. Because of the buildup of fats, these cells don't work as they should and, over time, the cells die. Niemann-Pick disease can affect the brain, nerves, liver, spleen and bone marrow. Sometimes it can affect the lungs.
Symptoms of Niemann-Pick disease relate to worsening function of the nerves, brain and other organs over time.
Niemann-Pick disease can happen at different ages but mainly affects children. The condition has no known cure and is sometimes fatal. Treatment is focused on helping people live with their symptoms.
The three main types of Niemann-Pick disease are called A, B and C. Symptoms differ widely but depend in part on the type and how severe the condition is. Symptoms may include:
Some infants with type A show symptoms within the first few months of life. Those with type B may not show symptoms for years and have a better chance of living to adulthood. People with type C can start to have symptoms at any age but may not have any symptoms until adulthood.
If you have concerns about your child's growth and development, talk with your healthcare professional. If your child is no longer able to do some activities that could be done before, see your healthcare professional right away.
Niemann-Pick disease is caused by changes in specific genes related to how the body breaks down and uses fats. These fats include cholesterol and lipids. The gene changes are passed from parents to children in a pattern called autosomal recessive inheritance. This means that both the mother and the father must pass on a changed gene for the child to have the condition.
There are three types of Niemann-Pick disease: A, B and C.
Niemann-Pick disease types A and B are both caused by changes in the SMPD1 gene. The condition is sometimes called acid sphingomyelinase deficiency (ASMD). With these gene changes, an enzyme called sphingomyelinase (sfing-go-MY-uh-lin-ase) is missing or doesn't work well. This enzyme is needed to break down and use lipids called sphingomyelin inside cells. A buildup of these fats causes cell damage, and over time, the cells die.
Type A ― the most severe form ― begins in infancy. Symptoms include a liver that becomes too large, severe brain damage and nerve loss that worsens over time. There is no cure. Most children do not live past a few years of age.
Type B ― sometimes called juvenile-onset Niemann-Pick disease ― usually begins later in childhood. It does not involve damage to the brain. Symptoms include nerve pain, problems walking, vision problems, and a liver and spleen that become too large. Lung problems also can happen. Most people with type B live into adulthood. But liver and lung problems worsen over time. Some people have symptoms that overlap between types A and B.
Niemann-Pick disease type C is caused by changes in the NPC1 and NPC2 genes. With these changes, the body doesn't have the proteins it needs to move and use cholesterol and other lipids in cells. Cholesterol and other lipids build up in the cells of the liver, spleen or lungs. Over time, the nerves and brain also are affected. This causes problems with eye movements, walking, swallowing, hearing and thinking. Symptoms vary widely, can appear at any age and get worse over time.
Risk factors for Niemann-Pick disease depend on the type. The condition is caused by changes in genes that are passed down in families. Although the condition can occur in any population, type A occurs more often in people of Ashkenazi Jewish descent. Type B occurs more often in people of North African descent. Type C occurs in many different populations, but it occurs more often in people of Acadian and Bedouin descent.
If you have a child with Niemann-Pick disease, your risk of having another child with the condition is higher.
Genetic testing and counseling can help you learn about your risks.
Diagnosis of Niemann-Pick disease begins with a physical exam. The exam may show an early warning sign such as a liver or spleen that is too large. Your healthcare professional talks with you about symptoms and your family health history. Niemann-Pick disease is rare, and its symptoms can be similar to those of other health conditions, so testing is needed to get the right diagnosis.
Diagnostic tests depend on the type of Niemann-Pick disease.
Other tests also may be done, such as:
Genetic testing and counseling for families with a child with Niemann-Pick disease can give information about risks and family planning options.
No cure exists for Niemann-Pick disease, but supportive care can help manage symptoms.
For Niemann-Pick disease type B, olipudase alfa-rpcp (Xenpozyme) is an enzyme replacement for missing or low levels of the sphingomyelinase enzyme. This enzyme replacement may help with lung problems and breathing and lessen the size of the liver and spleen. The medicine also may help height growth in children. It does not help with nerve-related symptoms.
Olipudase alfa-rpcp is given through a vein every two weeks.
For people with Niemann-Pick disease type C who have mild to moderate nerve symptoms, a drug called miglustat may be an option. Miglustat is approved for neurological symptoms of Niemann-Pick disease type C in many countries but is not approved by the U.S. Food and Drug Administration for this use in the United States.
Miglustat is a pill that's taken 1 to 3 times a day. Miglustat may slow the worsening of nerve symptoms such as problems with hearing, swallowing and walking. It also may help slow changes in mental health and learning and memory.
Discuss medicines, including possible side effects, with your doctor or other healthcare professional.
Therapies for all types of Niemann-Pick disease depend on symptoms and may include:
People with Niemann-Pick disease need to see their healthcare professionals regularly, because the disease and its symptoms worsen over time. Research for new treatments is ongoing.
If you or your child is diagnosed with Niemann-Pick disease, your family may face challenges and uncertainties. One of the most difficult things about this condition is that it's not possible to predict how health and development will change over time.
You or your child will likely require more care as the condition changes. Ask your healthcare team about supportive resources. Also talk with your healthcare team about when it's time to plan end-of life care.
You may find it helpful to connect with others who are living with Niemann-Pick disease. Depending on your needs, ask for information on organizations that support parents who have children with physical conditions that limit their abilities or who have lost children to such conditions.
Being part of clinical trials may help in the search for effective treatments.
Signs of Niemann-Pick disease may be noticed before birth. Or you may first share your concerns with a healthcare professional. After an exam, you may be referred to one or more specialists for testing and treatment.
You may want to ask a trusted family member or friend to join you for the appointment. Take someone along who can offer emotional support and can help you remember all of the information.
Here's some information to help you get ready for your first appointment.
Before your appointment, make a list of:
Questions to ask may include:
Questions to ask if you're referred to a specialist include:
Don't hesitate to ask other questions during your appointment.
Questions from your healthcare professional may include:
Be ready to answer questions so you have time to discuss what's most important to you.